<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00248768</url>
  </required_header>
  <id_info>
    <org_study_id>B3357-R</org_study_id>
    <secondary_id>Emory IRB 601-2004</secondary_id>
    <nct_id>NCT00248768</nct_id>
    <nct_alias>NCT00449371</nct_alias>
  </id_info>
  <brief_title>Accelerated Transcranial Magnetic Stimulation (TMS) for Depression</brief_title>
  <acronym>ATMS</acronym>
  <official_title>Accelerated Transcranial Magnetic Stimulation for Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>US Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determinate if accelerated rTMS treatment over 1.5 days is&#xD;
      effective for ameliorating depression in Parkinson's disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: The goal of this study is to investigate a new approach to administering&#xD;
      repetitive transcranial magnetic stimulation (rTMS) in patients with refractory depression.&#xD;
      (Please Note: The original requirement for comorbid Parkinson's disease has been dropped from&#xD;
      this study).&#xD;
&#xD;
      Research Plan: This inpatient study will provide an initial test for the hypothesis that&#xD;
      accelerated rTMS is an effective treatment for depression. Followup testing will help&#xD;
      delineate the time course of response.&#xD;
&#xD;
      Methods: The rTMS treatment site over left dorsolateral prefrontal cortex will be 5.5cm&#xD;
      anterior to the hand motor area. Treatments consisting of 1000 total pulses at 10 Hz and 100%&#xD;
      motor threshold will be administered hourly for 1.5 days, totaling 15 sessions. A&#xD;
      comprehensive test battery will be administered just before and after treatment, at 3 weeks,&#xD;
      and at 6 weeks after treatment.&#xD;
&#xD;
      Clinical Relevance: We expect that accelerated rTMS treatments will lessen the degree of&#xD;
      depression to the same extent as rTMS treatments of longer duration, but far more rapidly. A&#xD;
      much shorter hospitalization would be more easily tolerated. In addition, reducing the&#xD;
      duration of hospitalization substantially reduces burdens and costs to hospital, staff, and&#xD;
      caregivers, while more rapidly enhancing function and quality of life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Depression Scale</measure>
    <time_frame>2-42 days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial magnetic Stimulator</intervention_name>
    <description>a device which produces intense magnetic fields in the brain and activates cerebral neurons</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-80 years.&#xD;
&#xD;
          -  Patients who meet DSM-IV criteria for Major Depressive Episode, severe, treatment&#xD;
             resistant, with or without psychotic features.&#xD;
&#xD;
          -  Consent to treatment with rTMS.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with Delirium or Substance Dependence within the last 6 months. Patients will&#xD;
             be screened initially with the Michigan Alcohol Screening Test (MAST) and Mini-Mental&#xD;
             Status Examination and further evaluated if clinically indicated.&#xD;
&#xD;
          -  Patients with other significant central neurological disorders including increased&#xD;
             intracranial pressure, brain mass, epileptic seizures, stroke, transient ischemic&#xD;
             attack within two years, cerebral aneurysm, dementia, multiple sclerosis or other&#xD;
             major CNS dysfunction.&#xD;
&#xD;
          -  Pregnant women.&#xD;
&#xD;
          -  Patients with cardiac pacemakers, other intracardiac lines, cochlear implants,&#xD;
             aneurism clips, or other intracranial implants with the exception of dental fillings.&#xD;
&#xD;
          -  Patients with significant heart disease or with acute, unstable medical conditions&#xD;
             that require stabilization (e.g., uncontrolled hypertension, bleeding) prior to&#xD;
             treatment.&#xD;
&#xD;
          -  Patients who require continued treatment with antipsychotics including clozapine and&#xD;
             risperidone, benzodiazepines, lithium or anticonvulsants. Patients will be allowed to&#xD;
             continue on a stable dose of antidepressants and use zolpidem, since the latter is not&#xD;
             felt to affect seizure threshold.&#xD;
&#xD;
          -  Patients who are unable to ambulate independently and complete the assessment&#xD;
             protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Atlanta VA Medical and Rehab Center, Decatur</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, Epstein CM. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety. 2010 Oct;27(10):960-3. doi: 10.1002/da.20731.</citation>
    <PMID>20734360</PMID>
  </results_reference>
  <verification_date>September 2014</verification_date>
  <study_first_submitted>November 2, 2005</study_first_submitted>
  <study_first_submitted_qc>November 2, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2005</study_first_posted>
  <last_update_submitted>September 18, 2014</last_update_submitted>
  <last_update_submitted_qc>September 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>Parkinson Disease</keyword>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

